David Todd Stevens, Chief Capital Officer, on May 14, 2026, sold 47,064 shares in Figure Technology Solutions (FIGR) for $1,993,099. Following the Form 4 filing with the SEC, Stevens has control over a total of 406,051 Class A common shares of the company, with 406,051 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/2064124/000149315226023924/xslF345X05/ownership.xml
James Edgemond, CFO and Treasurer, on May 14, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,744,746. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000163617826000018/xslF345X05/primarydocument.xml
Arthur Reginald Collins, Director, on May 14, 2026, sold 2,300 shares in Aflac (AFL) for $268,065. Following the Form 4 filing with the SEC, Collins has control over a total of 6,186 common shares of the company, with 6,186 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/4977/000000497726000089/xslF345X05/wk-form4_1778879054.xml
Michael Scott Cagney, 10% Owner, Director, on May 10, 2026, sold 35,190 shares in Figure Technology Solutions (FIGR) for $1,344,274. Following the Form 4 filing with the SEC, Cagney has control over a total of 6,146,654 Class A common shares of the company, with 6,146,654 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2064124/000149315226023907/xslF345X05/ownership.xml